Диссертация (1140154), страница 23
Текст из файла (страница 23)
284-9198.Frustaci A, Verardo R, Caldarulo M, et al. Myocarditis in hypertrophiccardiomyopathy patients presenting acute clinical deterioration. Eur Heart J2007;28:733-74099.Fu M. Autoimmunity and idiopathic dilated cardiomyopathy: where westand? Autoimmunity 2008; 41:415–418100.Fujioka S, Kitaura A, Deguchi H, et al. Evaluation of viral infection in themyocardium of patients with idiopathic dilated cardiomyopathy. J Am CollCardiol 2000;36:1920–1926101.Fujita T, Ishikawa Y. Apoptosis in heart failure: The role of the β-adrenergicreceptor-mediated signaling pathway and p53-mediated signaling pathway in theapoptosis of cardiomyocytes [Review]. Circ J 2011; 75: 1811 – 1818102.
Fukae S, Ashizawa N, Morikawa S, Yano K. A fatal case of fulminantmyocarditis with human herpesvirus-6 infection. Intern Med 2000;39:632-636103. Gahide G, Bertrand D, Roubille R, et al. MR delayed enhancement imagingfindings in suspected acute myocarditis. Eur Radiol.2010;20:65–72104.Gore I., Saphir O. Myocarditis: a classification of 1402 cases. Am Heart J1947;34:827 – 830105. Greenwood RD, Nadas AS, Fyler DC.
Theclinical course of primarymyocardial disease in infants and children. Am Heart J 1976;92:549-560106. Griffin LD, Kearney D, Ni J, et al. Analysis of formalin-fixed and frozenmyocardial autopsy samples for viral genome in childhood myocarditis anddilated cardiomyopathy with endocardial fibroelastosis using polymerase chainreaction (PCR). Cardiovasc Pathol 1995;4:3-11107. Griffiths P.D., Hannington G., Booth J.C. Coxsackie B virus infections andmyocardial infarction: results from a prospective, epidemiologically controlledstudy. Lancet.
1980;1:1387 – 1389143108. Gullestad L, Aukrust P. Review of trials in chronic heart failure showing broadspectrum anti-inflammatory approaches. Am J Cardiol 2005; 95 (11A):17C–23C109. Gutberlet M, Spors B, Thoma T, et al. Suspected chronic myocarditis at cardiacMR: diagnostic accuracy and association with immunohistologically detectedinflammation and viral persistence. Radiology 2008;246:401-409110.
Hare J. The dilated restrictive cardiomyopathies. – Braunwald: Braunwald’sHeart Disease, 2008. – P. 1739-1762.111.Herda LR, Felix SB, Boege F. Drug-like actions of autoantibodies againstreceptors of the autonomous nervous system and their impact on human heartfunction. Br J Pharmacol. 2012;166:847–857112.Herskowitz A, Campbell S, Deckers J et al. Demographic features andprevalence of idiopathic myocarditis in patients undergoing endomyocardialbiopsy. Am J Cardiol.
1993;71:982–986113.Herskowitz A, Neumann DA, Rose NR, et al. Histocompatibility (MHC)antigens in human myocarditis: new markers of immune-mediated disease(abstract). Circulation 1989;80 Suppl 2:II-676114.Herskowitz A, Wu TC, Willoughby SB, et al. Myocarditis and cardiotropic viralinfection associated with severe left ventricular dysfunction in late-stage infectionwith human immunodeficiency virus. J Am Coll Cardiol 1994;24:1025-1032115. Heymans S.
Myocarditis and heart failure: need for better diagnostic, predictiveand therapeutic tools. Eur Heart J. 2007;28:1279-1280116. Hjalmarson A, Fu M, Mobini R. Who are the enemies? Inflammation andautoimmune mechanisms. Eur Heart J 2002; 4 (Suppl G):27–32117.Holzmann M, Nicko A, Kühl U, et al. Complication rate of right ventricularendomyocardial biopsy via the femoral approach: a retrospective and prospectivestudyanalyzing3048diagnosticproceduresoveran11-yearperiod.
Circulation 2008;118:1722-1728118.Hosenpud JD, McAnulty JH, Niles NR. Unexpected myocardial disease inpatients with life threatening arrhythmias. Br Heart J 1986;56:55-61144119.Hufnagel G, Maisch B. Expression of MHC class I and II antigens and the Il-2receptor in rejection, myocarditis and dilated cardiomyopathy. Eur Heart J1991;12 Suppl D:137-140120. Hufnagel G, Pankuweit S, Richter A et al. The European Study ofEpidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID).First epidemiological results. Herz. 2000; 25(3): p. 279-85121. Ishida K, Wada H, Sakakura K et al. Long-term follow-up on cardiac functionfollowingfulminantmyocarditisrequiringpercutaneousextracorporealcardiopulmonary support.
Heart Vessels. 2013 Jan;28(1):86-90122.Jahns R, Boivin V, Schwarzbach V et al. Pathological autoantibodies incardiomyopathy. Autoimmunity. 2008; 41:454–461123.James KB, Lee K, Thomas JD, et al. Left ventricular diastolic dysfunction inlymphocytic myocarditis as assessed by Doppler echocardiography. Am J Cardiol1994;73:282-285124. Jin O, Sole MJ, Butany JW, et al. Detection of enterovirus RNA in myocardialbiopsies from patients with myocarditis and cardiomyopathy using geneamplification by polymerase chain reaction. Circulation. 1990;82:8 –16125. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammationand cell death: learning from the past for the future.
Circulation. 1999;99:1091–1100126. Kaya Z, Afanasyeva M, Wang Y, et al. Contributions of the innate immunesystem to autoimmune myocarditis: a role for complement. Nat Immunol.2001;2:739 –745127. Kaya Z, Leib C, Katus HA. Autoantibodies in heart failure and cardiacdysfunction. Circ Res.2012 Jan 6;110(1):145–58128.Keeling PJ, Poloniecki LA, Caforio AL et al. A prospective case-control studyof antibodies to Coxsackie B virus in idiopathic dilated cardiomyopathy. J AmColl Cardiol. 1994;23:593 – 598129.Khaw BA, Narula J, Sharaf AR,et al. SR-Ca2+ ATPase as an autoimmunogen inexperimental myocarditis.
Eur Heart J 1995;16 Suppl O:92-96145130.Kindermann I, Barth C, Mahfoud F et al. Update on myocarditis. J Am CollCardiol 2012;59:779-792131. Klein R, Maisch B, Kochsiek K, Berg PA. Demonstration of organ specificantibodies against heart mitochondria (anti-M7) in sera from patients with someforms of heart diseases. Clin Exp Immunol 1984;58:283-292132.Klein R, Seipel L, Kleemann U, et al. Relevance of antimitochondrial antibodies(anti-M7) in cardiac diseases.
Eur Heart J (Suppl J) 1987;8:223-226133.Klingel K, Hohenadl C, Canu A, et al. Ongoing enterovirus-induced myocarditisis associated with persistent heart muscle infection: quantitative analysis of virusreplication, tissue damage, and inflammation. Proc Natl Acad Sci USA 1992;89:314–318134. Kobayashi Y, Yazawa T, Baba T et al. Clinical, electrophysiological, andhistopathological observations in supraventricular tachycardia. Pacing ClinElectrophysiol.
1988;11(8): р. 1154-67135.Koepsell SA, Anderson DR, Radio SJ. Parvovirus B19 is a bystander in adultmyocarditis. Cardiovasc Pathol. 2012; 21(6): 476-81136.Kopecky SL, Gersh BJ, McGoon MD, et al. The natural history of lone atrialfibrillation:apopulation-basedstudyoverthreedecades. NEnglJMed. 1987;317:669-674137. Korkusuz H, Esters P, Naguib N, et al. Acute myocarditis in a rat model: lategadoliniumenhancementwithhistopathologicalcorrelation.EurRadiol. 2009;19:2672–2678138.Kuethe F, Lindner J, Matschke K et al. Prevalence of parvovirus B19 and humanbocavirus DNA in the heart of patients with no evidence of dilatedcardiomyopathy or myocarditis. Clin Infect Dis. 2009; 49(11): 1660-6139.Kuhl U, Pauschinger M, Noutsias M, et al.
High prevalence of viral genomesand multiple viral infections in the myocardium of adults with ―idiopathic‖ leftventricular dysfunction. Circulation. 2005;111: 887– 893140. Kuhl U, Pauschinger M, Schwimmbeck PL, et al. Interferon-beta treatmenteliminates cardiotropic viruses and improves left ventricular function in patients146with myocardial persistence of viral genomes and left ventricular dysfunction.Circulation 2003;107:2793–2798141.Kuhl U, Pauschinger M, Seeberg B, et al. Viral persistence in the myocardium isassociated with progressive cardiac dysfunction. Circulation 2005;112:1965–1970142.Kuhl U, Schultheiss HP. Myocarditis in children.
Heart Fail Clin. 2011;6:483–96143.Kühl U, Schultheiss HP. Viral myocarditis. Swiss Med Wkly. 2014 Oct2;144:w14010144.Kuhl U, Ulrich G, Melzner B, et al. Characterization of autoantibodies againstthe Ca2+-channel inducing cytotoxicity by enhancement of calcium permeability.In: Seventh International Congress of Immunology, July 30-August 5, 1989:Abstracts. Stuttgart: Gustav Fischer, 1989:116-117145. Kunkel B, Lapp G, Kober G, et al. Light microscopic evaluation of myocardialbiopsies. In: Kaltenbach M, Loogen F, Olsen EGJ, eds. Cardiomyopathy andmyocardial biopsy. Berlin:Springer-Verlag, 1978:62-70146. Kytö V, Saraste A, Saukko P, et al. Apoptotic cardiomyocyte death in fatalmyocarditis. Am J Cardiol. 2004;94(6):746-50147.
Kytö V, Saukko P, Lignitz E, et al. Diagnosis and presentation of fatalmyocarditis. Hum Pathol 2005;36:1003-1007148. Laissy JP, Hyafil F, Feldman LJ, et al. Differentiating acute myocardialinfarction from myocarditis: diagnostic value of early- and delayed-perfusioncardiac MR imaging. Radiology 2005;237:75-82149. Laissy JP, Messin B, Varenne O, et al. MRI of acute myocarditis: acomprehensiveapproachbasedonvariousimagingsequences.Chest2002;122:1638-1648150. Lauer B, Niederau C, Kuhl U, et al. Cardiac troponin T in patients withclinically suspected myocarditis. J Am Coll Cardiol 1997;30:1354-1359147151.Lauer B, Schannwell M, Kuhl U, et al. Antimyosin autoantibodies are associatedwith deterioration of systolic and diastolic left ventricular function in patientswith chronic myocarditis. J Am Coll Cardiol 2000;35:11–18152.Leone O, Veinot JP, Angelini A et al.
Consensus statement on endomyocardialbiopsy from the Association for European Cardiovascular Pathology and theSociety for Cardiovascular Pathology. Cardiovasc Pathol 2012;21:245-274153.Leuschner F, Katus HA, Kaya Z. Autoimmune myocarditis: Past, present andfuture. Journal of Autoimmunity. 2009; 33:282–289154.Levin MJ, Hoebeke J. Cross-talk between anti-beta1-adrenoceptor antibodies indilated cardiomyopathy and Chagas’ heart disease.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
